Press release from Business Wire
ARIAD to Present at Upcoming Investor Conferences
Tuesday, June 04, 2013
ARIAD to Present at Upcoming Investor Conferences07:30 EDT Tuesday, June 04, 2013
CAMBRIDGE, Mass. (Business Wire) -- ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will provide an overview of the Company's business at two upcoming investor conferences being held next week:
- The William Blair Growth Stock Conference in Chicago. Timothy P. Clackson, Ph.D., president of research and development and chief scientific officer, will present on Tuesday, June 11 at 8:10 a.m. (CT).
- The Goldman Sachs 34th Annual Global Healthcare Conference in Rancho Palos Verdes, CA. Harvey J. Berger, M.D., chairman and chief executive officer, will present on Tuesday, June 11 at 2:40 p.m. (PT)
Both presentations will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts and Lausanne, Switzerland, is an integrated global oncology company focused on transforming the lives of cancer patients with breakthrough medicines. ARIAD is working on new medicines to advance the treatment of various forms of chronic and acute leukemia, lung cancer and other difficult-to-treat cancers. ARIAD utilizes computational and structural approaches to design small-molecule drugs that overcome resistance to existing cancer medicines. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).
ARIAD Pharmaceuticals, Inc.
Kendra Adams, 617-503-7028
Liza Heapes, 617-621-2315